sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
AKTS
Updated 10/6/2026, 1:28 PM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| AKTS Aktis Oncology, Inc. | Sale | $258,621 | Czibere Akos Chief Medical Officer | 12,500 sh | at $20.69 | Filed Sep 24, 4:05 PM ET | Filing | |
| AKTS Aktis Oncology, Inc. | Sale | $119,274 | Herrmann Ken Director | 4,856 sh | at $24.56 | Filed Jul 21, 8:50 PM ET | Filing | |
| AKTS Aktis Oncology, Inc. | Sale | $77,259 | Herrmann Ken Director | 3,065 sh | at $25.21 | Filed Jul 20, 5:34 PM ET | Filing | |
| AKTS Aktis Oncology, Inc. | Sale | $1,387,558 | Ron-Bigger Shulamit Chief Operating Officer | 50,000 sh | at $27.75 | Filed Jul 10, 6:11 AM ET | Filing | |
| AKTS Aktis Oncology, Inc. | Sale | $1,388,701 | Czibere Akos Chief Medical Officer | 50,000 sh | at $27.77 | Filed Jul 10, 6:10 AM ET | Filing |